[1] | Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. J Epilepsia 2014; 55:475- 82. doi: 10.1111/epi.12550. |
[2] | Mellish LC, Dunkley C, Ferrie CD, et al. Antiepileptic drug treatment of Rolandic epilepsy and Panayiotopoulos syndrome: Clinical practice survey and clinical tial feasibility. J Arch Dis Child 2015; 100(1): 62-7. doi: 10.1136/archdischild-2013-304211. |
[3] | Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med 1993; 22:1337–1348. |
[4] | Daghistani R, Widjaja E. Role of MRI in patient selection for surgical treatment of intractable epilepsy in infancy. Brain Dev 2013; 35:697–705. |
[5] | Tellez-Zenteno JF, Hernandez Ronquillo L, Moien-Afshari F, et al. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res 2010; 89: 310–318. |
[6] | Bronen RA, Fulbright RK, Spencer DD, et al. Refractory epilepsy: comparison of MR imaging, CT, and histopathologic findings in 117 patients. Radiology 1996; 201(1): 97-105. |
[7] | Scott CA, Fish DR, Smith SJ, et al. Presurgical evaluation of patients with epilepsy and normal MRI: role of scalp video-EEG telemetry. J Neurol Neurosurg Psychiatry 1999; 66 (1): 69-71, http://dx.doi.org/10.1136/jnnp.66.1.69. |
[8] | Winston GP, Micallef C, Kendell BE, et al. The value of repeat neuroimaging for epilepsy at a tertiary referral centre: 16 years of experience. Epilepsy Res 2013; 105:349–355. |
[9] | De Coene B, Hajnal JV, Gatehouse P, et al. MRI of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. AJNR Am J Neuroradiol 1992; 13:1555–1564. |
[10] | Modi S, Tripathi M, Saha S, et al. Seizures in patients with idiopathic hypoparathyroidism: effect of antiepileptic drug withdrawal on recurrence of seizures and serum calcium control. Eur J Endocrinol 2014; 170(5):777-83. |
[11] | Hussein R, Soliman R, Abdelhaleem M, et al. Effect of antiepileptic drugs on liver enzymes Beni-Suef University Journal of Basic and Applied Sciences 2013; 2(1): 14-9. doi.org/10.1016/j. bjbas.2013,09.002. |
[12] | Ndrepepa G, Kastrati A. Gamma-glutamyl transferase and cardiovascular diseases. Ann Transl Med 2016; 4(24): 481. doi:10.21037/atm.2016.12.27. |
[13] | Brodie MJ, Mintzer S, Pack AM, et al. Enzyme induction with antiepileptic drugs: Cause for concern? Epilepsia 2013; 54(1): 11-27. doi: 10.1111/j.1528-1167.2012.03671. |
[14] | Rogawski MA. Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 2006; 69:273–294. |
[15] | Perucca E, French J, Bialer M. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol 2007; 6:793–804. |
[16] | Kwan P, Brodie MJ. Combination therapy in epilepsy: when and what to use. Drugs 2006; 66:1817–1829. |
[17] | Snedecor GM, Cochran, WG. Statistical methods-7th edition lowa state Univ., Press Ames loww3a, USA 1982: 325-330. |
[18] | Blume W, Lüders H, Mizrahi E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42(9): 1212-8, http://dx.doi.org/10.1046/j.1528-1157.2001.22001.x. |
[19] | Schachter SC. Currently available antiepileptic drugs. Neurotherapeutics 2007; 4:4–11. |
[20] | Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93:3908–3913. |
[21] | MacQuuen GM, Campbell S, McEwen BS, et al. Course of illness, hippocampal function and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003; 100: 1387–1392. |
[22] | Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003; 160: 1516–1518. |
[23] | Hitiris N, Mohanraj R, Norrie J, et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007; 75:192–196. |
[24] | Petrovski CE, Szoecke NC, Jones NC, et al. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology 2010; 75:1015–1021. |
[25] | Jack CR, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology 1990; 175:423–429. |
[26] | Cendes F, Leproux F, Melanson D, et al. MRI of amygdala and hippocampus in temporal lobe epilepsy. J Comput Assist Tomogr 1993; 17:206–210. |
[27] | Kim JH, Tien RD, Felsberg GJ, et al. MR measurements of the hippocampus for lateralization of temporal lobe epilepsy: value of measurements of the body vs the whole structure. AJR Am J Roentgenol 1994; 163:1453–1457. |
[28] | Barkhof F, Scheltens P. Imaging of white matter lesions. Cerebrovasc Dis 2002; 13(2): 21–30. |
[29] | Simon JH, Li D, Traboulsee A, et al. Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol 2006; 27(2): 455–461. |
[30] | Filippi M, Rocca MA, De Stefano N, et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 2011; 68(12): 1514–1520. |
[31] | Seon YL, Eunju S, Yoosoo C. Elevated Serum Gamma-Glutamyltransferase Is a Strong Marker of Insulin Resistance in Obese Children. International Journal of Endocrinology. Volume 2013 (2013), http://dx.doi.org/10.1155/2013/578693. |
[32] | Berno G, Zaccarelli M, Gori C, et al. Analysis of single-nucleotide polymorphism (SNPs) in human CYP3A4 and CYP3A5 genes:potential implications for the metabolism of HIV drugs. BMC Med Genet 2014; 15:76. doi: 10.1186/1471-2350-15-76. |
[33] | Shokry E, Villanelli F, Malvagia S, et al. Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectroscopy. J Pharm Biomed Anal 2015; 109: 164-70. doi:10.1016/j.jpba.2015.02.045. |
[34] | Hueng-CF, Herng-Shen L, Kai-Ping C. The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism. Int J Mol Sci. 2016; 17(8). pii:E 1242. doi:10.3390/ijms17081242. |
[35] | Aldenkamp A, Vigevano F, Arzimanoglou A, et al. Role of valproate across the ages. Treatment of epilepsy in children. Acta Neurol Scand 2006; 184:1-13. |
[36] | Yılmaz U, Yılmaz TS, Akıncı G, et al. The effect of antiepileptic drugs on thyroid function in children. Seizure. 2014, 23(1): 29-35. doi: 10.1016/j.seizure.2013.09.006. |
[37] | Davis R, Peters DH, McTavish D. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1994; 47:332-72. |
[38] | Lee DH, Blomhoff R, Jacobs DR. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004, 38: 535–539. |
[39] | Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263–355. |
[40] | Reynaud M, Schellenberg F, Loisequx-Meunier MN, et al. Objective diagnosis of alcohol abuse: compared values of carbohydratedeficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV). Alcohol Clin Exp Res 2000; 24: 1414–1419. |
[41] | Sun AY, Sun GY. Ethanol and oxidative mechanisms in the brain. J Biomed Sci 2001; 8: 37–43. |
[42] | Conigrave KM, Degenhardt LJ, Whitfield JB, et al. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 2002; 26: 332–339. |
[43] | Caballeria J. Current concepts in alcohol metabolism. Ann Hepatol 2003; 2: 60–68. |
[44] | Niemelä O. Biomarkers in alcoholism. Clin Chim Acta 2007; 377: 39–49. |
[45] | Lçscher W, Wauquier A. Use of animal models in developing guiding principles for polypharmacy in epilepsy. In Homan RW, Leppik IE, Lothman EW, Penry JK, Theodore WH (eds) Rational Polypharmacy; Epilepsy Research Supplements 11, Elsevier, Amsterdam, 1996; pp. 61–65. |
[46] | Czuczwar SJ, Borowicz KK. poly therapy in epilepsy: the experimental evidence. Epilepsy Res 2002; 52:15–23. |
[47] | Lçscher W. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 1998; 342:1–13. |
[48] | Dodge JC, Illig AM, Snyder PJ, et al. GABA levels within the medial preoptic area: effects of chronic administration of sodium valproic acid. Psychoneuroendocrinology 2000; 25: 519-34. |
[49] | Pugsley MK, Yu EJ, Mclean TH, et al. Blockade of neuronal sodium channels by the antiepileptic drugs phenytoin, carbamazepine and sodium valproate. Proc West Pharmacol Soc 1999; 42:105-8. |
[50] | Makarska-Bialek K, Kaminski RM, Czuczwar SJ. Influence of the antagonist of the glycine site of NMDA receptors, MRZ 2/576, on the anticonvulsant activity of conventional antiepileptic drugs in mice. Pharmacol Rep 2005; 57:458-66. |
[51] | Deckers CL, Czuczwar SJ, Hekster YA, et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000; 41:1364–1374. |
[52] | Jonker DM, Voskuyl RA, Danhof M. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments? Epilepsia 2007; 48:412–434. |